当前位置:首页 - 行情中心 - 博雅生物(300294) - 财务分析

博雅生物

(300294)

  

流通市值:87.84亿  总市值:87.84亿
流通股本:5.04亿   总股本:5.04亿

博雅生物(300294)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.30亿元,每股收益0.06元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益746328.83万元,未分配利润265201.98万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产840608.73万元,负债94279.90万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入321,128,375.862,059,088,027.171,473,924,123.261,007,772,869.56
营业总成本296,220,781.811,738,837,657.081,228,094,382.4806,442,005.67
其他经营收益
营业利润37,147,624.59109,422,428.38342,345,308.49262,723,884.73
利润总额36,003,508.55103,878,495.08341,334,751.51263,486,107.21
净利润30,033,392.25112,638,772.02343,042,957.61225,409,614.24
每股收益
其他综合收益-5,943,787.21-5,885,761.41-3,039,859.77-3,337,574.7
综合收益总额24,089,605.04106,753,010.61340,003,097.84222,072,039.54
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计4,954,223,849.135,233,637,231.145,114,533,961.354,997,937,423.71
非流动资产:
非流动资产合计3,451,863,453.363,392,542,141.393,612,576,945.823,679,934,943.41
资产总计8,406,087,302.498,626,179,372.538,727,110,907.178,677,872,367.12
流动负债:
流动负债合计784,509,138.111,033,795,419.63918,495,852.52897,877,703.48
非流动负债:
非流动负债合计158,289,882.79153,185,276.35136,166,290.87149,839,647.46
负债合计942,799,020.91,186,980,695.981,054,662,143.391,047,717,350.94
所有者权益(或股东权益):
归属于母公司股东权益合计7,461,923,537.637,437,646,428.787,670,755,764.467,628,474,485.53
股东权益合计7,463,288,281.597,439,198,676.557,672,448,763.787,630,155,016.18
负债和股东权益合计8,406,087,302.498,626,179,372.538,727,110,907.178,677,872,367.12
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计349,111,915.071,856,187,215.041,363,006,049.57901,172,454.7
经营活动现金流出小计476,341,282.311,795,024,527.461,336,895,407.69894,226,085.38
经营活动产生的现金流量净额-127,229,367.2461,162,687.5826,110,641.886,946,369.32
投资活动产生的现金流量:
投资活动现金流入小计2,286,067,267.445,227,394,023.254,859,083,102.042,263,830,406.25
投资活动现金流出小计2,468,543,430.765,908,308,549.075,222,844,043.062,481,267,931.04
投资活动产生的现金流量净额-182,476,163.32-680,914,525.82-363,760,941.02-217,437,524.79
筹资活动产生的现金流量:
筹资活动现金流入小计11,230,00048,035,988.72,162,988.7-
筹资活动现金流出小计4,424,857.87203,105,364.17201,272,412.8184,155,805.19
筹资活动产生的现金流量净额6,805,142.13-155,069,375.47-199,109,424.11-84,155,805.19
汇率变动对现金及现金等价物的影响-104,238.48-133,997.22-57,739.96-7,950.92
现金及现金等价物净增加额-303,004,626.91-774,955,210.93-536,817,463.21-294,654,911.58
期末现金及现金等价物余额220,611,552.13523,616,179.04761,753,926.761,003,916,478.39
补充资料:
现金及现金等价物的净增加额--774,955,210.93--294,654,911.58
最新报告期:2026-04-30
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中信证券陈竹,王凯旋0.600.680.812026-04-30
开源证券阮帅,余汝意0.480.550.702026-04-28
兴业证券孙媛媛,黄翰漾0.730.780.892026-04-14
国投证券胡雨晴0.570.630.692026-03-29
东海证券杜永宏0.620.690.762026-03-27
TOP↑